The influence of sublingual immunotherapy on quality of life in children with allergic rhinitis.
10.13201/j.issn.1001-1781.2018.02.004
- Author:
Gui YANG
1
;
Shu Qi QIU
1
;
Peng WANG
1
;
Dan CHEN
1
;
Sheng LI
1
;
Tian Yong HU
1
;
Li MA
1
;
Zhi Qiang LIU
1
Author Information
1. Longgang ENT Hospital,Institute of ENT Shenzhen,518172,China.
- Publication Type:Journal Article
- Keywords:
children;
desensitization therapy;
quality of life;
rhinitis, allergic
- MeSH:
Administration, Sublingual;
Child;
Humans;
Quality of Life;
Rhinitis, Allergic;
therapy;
Sublingual Immunotherapy;
Treatment Outcome
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2018;32(2):95-98
- CountryChina
- Language:Chinese
-
Abstract:
To analyze the impact of sublingual immunotherapy(SLIT)on the quality of life in children with allergic rhinitis.Fifty children with allergic rhinitis who have received sublingual immunotherapy were enrolled in this study.Quality of life was evaluated via measurement of VAS score and rhinoconjunctivitis quality of life questionnaire(RQLQ)before and after treatment.Twenty patients after treatment had complete remission,13 cases were partly alleviated and 17 cases had no response.The total effective rate was 66%.The Multi-VAS scores and Uni-VAS scores in each observation time point(at half a year,one year,two years after treatment)had statistically significant difference compared with that of pre-treatment with SLIT(<0.05).According to RQLQ scores,the quality of life,nasal symptoms,conjunctiva symptoms,non-nasal(ocular)symp-toms,behaviors and emotional responses were greatly improved in each time point compared with that of pretreatment(<0.05).Symptomatic treatment scores in each time point after treatment were significantly different and had a positive correlation with the scores of RQLQ(<0.05).SLIT can improve the nasal allergic symptoms,children's life quality and reduce the use of symptomatic treatment medicines.
